CIK 0001707502 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 8.1 M | |||
| Net income (USD) | ||||
| Diluted EPS (USD/shares) | -1.99 | -4.83 | -10.1 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 4 | 4 | 2026-10-18 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-08-14 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | 8-K | 8-K items 8.01,9.01 | 2026-08-06 |
| 2026-08-06 | 424B5 | 424B5 | |
| 2026-08-06 | S-3ASR | S-3ASR | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-30 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-07 | 4 | 4 | 2026-07-02 |
| 2026-06-24 | 3 | 3 | 2026-06-22 |
| 2026-06-24 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-11 | 4 | 4 | 2026-06-10 |
| 2026-06-10 | 8-K | 8-K items 5.07 | 2026-06-10 |
| 2026-06-05 | 424B7 | 424B7 | |
| 2026-05-12 | 10-Q | 10-Q | 2026-03-31 |
Forms on file (last 1,000): 4 336, 8-K 66, 3 39, 144 29, 10-Q 26, SC 13D/A 24, SC 13G/A 20, CORRESP 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SLDB (0.002 USD), /gw/filings/filings?ticker=SLDB&form=8-K, /gw/filings/facts?ticker=SLDB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange